Literature DB >> 18587712

MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients.

Arjan D Van Zuilen1, Jack F M Wetzels, Michiel L Bots, Peter J Van Blankestijn.   

Abstract

Moderate to severe chronic kidney disease (CKD) is associated with increased cardiovascular risk. Usually nephrologists are primarily responsible for the care of CKD patients. However, in many cases treatment goals, as formulated in guidelines, are not met. The addition of a nurse practitioner might improve the quality of care. The Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of Nurse Practitioners (MASTERPLAN) study is a randomized controlled multicenter trial, aimed at investigating whether a multifactorial approach in patients with moderate to severe CKD (stage 3 and 4) to achieving treatment goals using both a polydrug strategy and lifestyle treatment either with or without the addition of a nurse practitioner will reduce cardiovascular risk and slow the decline of kidney function. Patients (n=793) have been randomized to nurse care or physician care. In the nurse-care arm of the study, nurse practitioners use flowcharts to address risk factors requiring drug and/or lifestyle modification. They have been trained to coach patients by motivational interviewing with the aim of improving patient self-management. At baseline, both treatment groups show equal distributions with regard to key variables in the study. Moreover, in only 1 patient were all risk factors within the limits as defined in various guidelines, which underscores the relevance of our initiative.

Entities:  

Mesh:

Year:  2008        PMID: 18587712

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  17 in total

1.  Motivational interviewing promotes adherence and improves wellbeing in pre-dialysis patients with advanced chronic kidney disease.

Authors:  Helena García-Llana; Eduardo Remor; Gloria del Peso; Olga Celadilla; Rafael Selgas
Journal:  J Clin Psychol Med Settings       Date:  2014-03

2.  A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial.

Authors:  Brendan J Barrett; Amit X Garg; Ron Goeree; Adeera Levin; Anita Molzahn; Claudio Rigatto; Joel Singer; George Soltys; Steven Soroka; Dieter Ayers; Patrick S Parfrey
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

3.  Importance and benefits of dietary sodium restriction in the management of chronic kidney disease patients: experience from a single Chinese center.

Authors:  Wang Yu; Sun Luying; Wang Haiyan; Li Xiaomei
Journal:  Int Urol Nephrol       Date:  2011-05-21       Impact factor: 2.370

4.  Motivational interviewing to engage patients in chronic kidney disease management.

Authors:  Steve Martino
Journal:  Blood Purif       Date:  2011-01-10       Impact factor: 2.614

5.  Nurse practitioner care improves renal outcome in patients with CKD.

Authors:  Mieke J Peeters; Arjan D van Zuilen; Jan A J G van den Brand; Michiel L Bots; Marjolijn van Buren; Marc A G J Ten Dam; Karin A H Kaasjager; Gerry Ligtenberg; Yvo W J Sijpkens; Henk E Sluiter; Peter J G van de Ven; Gerald Vervoort; Louis-Jean Vleming; Peter J Blankestijn; Jack F M Wetzels
Journal:  J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 10.121

6.  Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study.

Authors:  Yvette Meuleman; Lucia Ten Brinke; Arjan J Kwakernaak; Liffert Vogt; Joris I Rotmans; Willem Jan W Bos; Paul J M van der Boog; Gerjan Navis; Gert A van Montfrans; Tiny Hoekstra; Friedo W Dekker; Sandra van Dijk
Journal:  Int J Behav Med       Date:  2015-08

7.  Motivational interviewing for patients with chronic kidney disease.

Authors:  Kathryn A Sanders; Amanda Whited; Steve Martino
Journal:  Semin Dial       Date:  2013-02-14       Impact factor: 3.455

8.  Patient perspectives on fluid management in chronic hemodialysis.

Authors:  Kimberly Smith; Melinda Coston; Kimberly Glock; Tom A Elasy; Kenneth A Wallston; T Alp Ikizler; Kerri L Cavanaugh
Journal:  J Ren Nutr       Date:  2009-11-13       Impact factor: 3.655

9.  Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.

Authors:  Brad C Astor; Kunihiro Matsushita; Ron T Gansevoort; Marije van der Velde; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Brad C Astor; Kunihiro Matsushita; Ron T Gansevoort; Marije van der Velde; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Meguid El-Nahas; Kai-Uwe Eckardt; Bertram L Kasiske; Jackson Wright; Larry Appel; Tom Greene; Adeera Levin; Ognjenka Djurdjev; David C Wheeler; Martin J Landray; John N Townend; Jonathan Emberson; Laura E Clark; Alison Macleod; Angharad Marks; Tariq Ali; Nicholas Fluck; Gordon Prescott; David H Smith; Jessica R Weinstein; Eric S Johnson; Micah L Thorp; Jack F Wetzels; P J Blankestijn; A D van Zuilen; Vandana Menon; Mark Sarnak; Gerald Beck; Florian Kronenberg; Barbara Kollerits; Marc Froissart; Benedicte Stengel; Marie Metzger; Giuseppe Remuzzi; Piero Ruggenenti; Annalisa Perna; H J Lambers Heerspink; Barry Brenner; Dick de Zeeuw; Peter Rossing; Hans-Henrik Parving; Priscilla Auguste; Kasper Veldhuis; Yaping Wang; Laura Camarata; Beverly Thomas; Tom Manley
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

10.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

Authors:  Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey
Journal:  JAMA       Date:  2012-05-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.